Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Timeline

Avego BioScience Capital

Biotech investment vehicle; participated in CellCentric's £170m Series D.

1 of 1 entries (1 events, 0 interactions)

Filters